Ichiro (paul) Mori
PRESIDENT AND CHIEF EXECUTIVE OFFICER
Teikoku Pharma USA Inc
United States of America
Paul Mori is co-founder, President and Chief Executive Officer of Teikoku Pharma USA (TPU) established in 1997. Mr. Mori brings over 35 years of international pharmaceutical business experience. While at TPU, he has established partnerships with major and mid-sized Pharmaceutical companies — among them Becton Dickinson, Bristol-Myers Squibb, Endo Pharmaceuticals, Grunenthal and Mundi Pharma etc. Prior to joining TPU, Mr. Mori worked for Alpha Therapeutic Corporation in Los Angeles, California as Associate Director of International Regulatory Affairs. While at Alpha he was involved in various product registrations of pharmaceutical/biological products in over 20 countries. Prior to Alpha Therapeutics Corporation, Mr. Mori held was an international operations manager for Green Cross Corporation (now Mitsubishi Tanabe Pharma) in Osaka, Japan. There, he was involved in Fluosol and Soyacal NDA approvals. Mr. Mori also serves as Chairman/Vice Chairman for JPMA-WEST (Japanese pharmaceutical industry association, US West coast region, voluntary organization). Mr. Mori received his bachelor’s degree from Kobe University in 1981.
Pharmaceutical care and therapeutics